Clinical Trials in Miami

Showing 4421-4440 of 6,922 trials

PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD

NCT03172481

This is a randomized, double-blind, parallel group, placebo-controlled, dose optimized, phase 3 study to evaluate the safety and efficacy of PRC-063 in the treatment of ADHD in pediatric subjects between 6 to 12 years of age.

ADHD

Purdue Pharma, Canada156 participantsStarted May 2017

Newport Beach, California, United States • Bradenton, Florida, United States • Maitland, Florida, United States +3 more locations

UNKNOWNPhase 2< 1 mile

Study in Subjects With Moderate Atopic Dermatitis

NCT03859986

This is a Phase 2, randomized, double-blind, vehicle-controlled, parallel-group study to evaluate the safety and efficacy of ALX-101 Gel 5% and a matching ALX-101 Gel Vehicle when applied topically twice daily for 56 days in adult and adolescent subjects with moderate atopic dermatitis

Atopic Dermatitis Eczema

Ralexar Therapeutics, Inc.124 participantsStarted Mar 2019

Beverly Hills, California, United States • Los Angeles, California, United States • Aventura, Florida, United States +19 more locations

PRC-063 Classroom Study in Children (6-12 Years of Age) With ADHD

Study in Subjects With Moderate Atopic Dermatitis

Find Trials by Condition in Miami

A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea

Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris

A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)

Trial of IMO-8400 in Adult Patients With Dermatomyositis

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

World-wide Randomized Antibiotic Envelope Infection Prevention Trial

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma

A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine

A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care

Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2

Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

Estimating Average Vitamin A Requirements in Indonesian and American Women